Insider trading is the trading of a company’s securities by individuals with access to confidential or material non-public information about the company.
A company is required to report trading by corporate officers, directors, or other company members with significant access to privileged information to the Securities and Exchange Commission (SEC).
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Reliance Global Grp Inc | Joel Markovits | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 0.21 per share. | 24 Mar 2026 | 127,562 | 127 (0%) | 0% | 0.2 | 26,214 | Common Stock |
| MeiraGTx Holdings PLC | Alexandria Forbes | Director, PRESIDENT & CEO | Sale of securities on an exchange or to another person at price $ 7.41 per share. | 24 Mar 2026 | 62,000 | 1,449,695 (3%) | 0% | 7.4 | 459,420 | Ordinary Shares |
| ServisFirst Bancshares Inc | Joseph Richard Cashio | Director | Sale of securities on an exchange or to another person at price $ 74.50 per share. | 24 Mar 2026 | 42,000 | 397,825 (0%) | 0% | 74.5 | 3,129,000 | Common Stock |
| Tejon Ranch Co. | Hugh F. McMahon | Executive VP- Real Estate | Grant, award, or other acquisition of securities at price $ 18.90 per share. | 24 Mar 2026 | 26,042 | 101,188 (0%) | 0% | 18.9 | 492,194 | Tejon Ranch Co. Common Stock |
| Tejon Ranch Co. | Michael R.W. Houston | Sr. VP & General Counsel | Grant, award, or other acquisition of securities at price $ 18.90 per share. | 24 Mar 2026 | 20,473 | 23,205 (0%) | 0% | 18.9 | 386,940 | Tejon Ranch Co. Common Stock |
| Tejon Ranch Co. | Robert D. Velasquez | SVP Finance/CAO | Grant, award, or other acquisition of securities at price $ 18.90 per share. | 24 Mar 2026 | 17,221 | 58,127 (0%) | 0% | 18.9 | 325,477 | Tejon Ranch Co. Common Stock |
| Tejon Ranch Co. | Hugh F. McMahon | Executive VP- Real Estate | Payment of exercise price or tax liability using portion of securities received from the company at price $ 18.90 per share. | 24 Mar 2026 | 12,864 | 88,324 (0%) | 0% | 18.9 | 243,130 | Tejon Ranch Co. Common Stock |
| Kelly Services Inc (Class A) | Christopher D. Layden | President, and CEO | Purchase of securities on an exchange or from another person at price $ 8.76 per share. | 24 Mar 2026 | 10,000 | 382,513 (1%) | 0% | 8.8 | 87,561 | Class A Common Stock, Par Value $1 |
| Tejon Ranch Co. | Robert D. Velasquez | SVP Finance/CAO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 18.90 per share. | 24 Mar 2026 | 9,559 | 48,568 (0%) | 0% | 18.9 | 180,665 | Tejon Ranch Co. Common Stock |
| Tejon Ranch Co. | Michael R.W. Houston | Sr. VP & General Counsel | Payment of exercise price or tax liability using portion of securities received from the company at price $ 18.90 per share. | 24 Mar 2026 | 8,541 | 14,664 (0%) | 0% | 18.9 | 161,425 | Tejon Ranch Co. Common Stock |
| Exzeo Group Inc | Paresh Patel | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 14.99 per share. | 24 Mar 2026 | 2,000 | 1,584,013 | - | 15.0 | 29,980 | Common Stock |
| BCP Investment Corp | David Held | Chief Compliance Officer | Purchase of securities on an exchange or from another person at price $ 7.35 per share. | 24 Mar 2026 | 938 | 1,258 (0%) | 0% | 7.3 | 6,894 | Common Stock |
| Franklin Fin Services Corp | Lorie M. Heckman | EVP, Chief Risk Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 Mar 2026 | 200 | 2,500 | - | - | Incentive Stock Option (Right to Buy) | |
| Franklin Fin Services Corp | Lorie M. Heckman | EVP, Chief Risk Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 34.10 per share. | 24 Mar 2026 | 200 | 7,150 (0%) | 0% | 34.1 | 6,820 | Common Stock |
| Kelly Services Inc (Class A) | Christopher D. Layden | President, and CEO | Purchase of securities on an exchange or from another person at price $ 13.52 per share. | 24 Mar 2026 | 100 | 100 (0%) | 0% | 13.5 | 1,352 | Class B Common Stock, Par Value $1 |
| Neuronetics Inc | Daniel L. Reuvers | President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Mar 2026 | 1,500,000 | 1,500,000 (8%) | 8% | 0 | Common Stock | |
| Haleon PLC (ADR) | Brian James McNamara | Chief Executive Officer and Director | 23 Mar 2026 | 1,497,695 | 2,762,967 (0%) | 0% | 0 | Ords 0.01p | ||
| Exact Sciences Corp | Kevin T. Conroy | Director, President and CEO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 23 Mar 2026 | 1,397,738 | 0 (0%) | 0% | - | Common Stock | |
| Haleon PLC (ADR) | Brian James McNamara | Chief Executive Officer and Director | Sale of securities on an exchange or to another person at price $ 3.68 per share. | 23 Mar 2026 | 704,974 | 2,057,993 (0%) | 0% | 3.7 | 2,597,420 | Ords 0.01p |
| Indaptus Therapeutics Inc | David Elliot Lazar | Director | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 23 Mar 2026 | 700,000 | 0 | - | - | Series AAA Convertible Non-Redeemable Preferred Stock | |
| Red Robin Gourmet Burgers Inc | David A. Pace | Director, PRESIDENT AND CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Mar 2026 | 250,000 | 250,000 | - | - | Phantom Restricted Stock Unit | |
| Red Robin Gourmet Burgers Inc | David A. Pace | Director, PRESIDENT AND CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Mar 2026 | 250,000 | 571,698 (4%) | 1% | 0 | Common Stock | |
| Exact Sciences Corp | Kevin T. Conroy | Director, President and CEO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 23 Mar 2026 | 235,388 | 0 | - | - | Stock Options (Right to Buy) | |
| Indaptus Therapeutics Inc | David Elliot Lazar | Director | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 23 Mar 2026 | 196,800 | 103,200 | - | - | Series AA Convertible Non-Redeemable Preferred Stock | |
| Exact Sciences Corp | Sarah Condella | EVP, Human Resources | Sale or transfer of securities back to the company at price $ 0.00 per share. | 23 Mar 2026 | 191,891 | 0 (0%) | 0% | - | Common Stock | |
| Establishment Labs Holdings Inc | Juan Jose Chacon Quiros | Director | Other type of transaction at price $ 0.00 per share. | 23 Mar 2026 | 179,240 | 1,257,504 (5%) | 0% | 0 | Common Shares | |
| Establishment Labs Holdings Inc | Juan Jose Chacon Quiros | Director | Other type of transaction at price $ 0.00 per share. | 23 Mar 2026 | 179,240 | 45,193 (0%) | 0% | 0 | Common Shares | |
| Exact Sciences Corp | Kevin T. Conroy | Director, President and CEO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 23 Mar 2026 | 154,829 | 0 | - | - | Restricted Stock Units | |
| Exact Sciences Corp | Jacob Orville | EVP, GM, Screening | Sale or transfer of securities back to the company at price $ 0.00 per share. | 23 Mar 2026 | 153,726 | 0 (0%) | 0% | - | Common Stock | |
| Amprius Tech Inc | Kang Sun | Director | Sale of securities on an exchange or to another person at price $ 18.69 per share. | 23 Mar 2026 | 152,823 | 121,452 | - | 18.7 | 2,855,696 | Common stock |
| Odyssey Marine Exploration Inc | Mark D. Gordon | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Mar 2026 | 150,000 | 0 | - | - | Stock Option(Right to Buy) | |
| Odyssey Marine Exploration Inc | Mark D. Gordon | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.41 per share. | 23 Mar 2026 | 150,000 | 632,235 (6%) | 1% | 0.4 | 62,115 | Common Stock |
| Arq Inc | Richard M. Campbell-Breeden | Director | Purchase of securities on an exchange or from another person at price $ 2.21 per share. | 23 Mar 2026 | 150,000 | 404,786 (2%) | 0% | 2.2 | 331,665 | Common Stock |
| Exact Sciences Corp | Aaron Bloomer | EVP, Chief Financial Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 23 Mar 2026 | 138,679 | 0 (0%) | 0% | - | Common Stock | |
| Exact Sciences Corp | Brian Baranick | EVP, GM, Precision Oncology | Sale or transfer of securities back to the company at price $ 0.00 per share. | 23 Mar 2026 | 137,195 | 0 (0%) | 0% | - | Common Stock | |
| Haleon PLC (ADR) | Brian James McNamara | Chief Executive Officer and Director | 23 Mar 2026 | 133,733 | 2,191,726 (0%) | 0% | 0 | Ords 0.01p | ||
| VSee Health Inc | Imoigele P. Aisiku | Director, Co-Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.37 per share. | 23 Mar 2026 | 128,342 | 3,545,031 | - | 0.4 | 47,487 | Common Stock, par value $0.0001 per share |
| Orchid Island Cap Inc | Robert E. Cauley | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Mar 2026 | 121,891 | 134,383 | - | - | Performance Units | |
| Orchid Island Cap Inc | Robert E. Cauley | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Mar 2026 | 121,891 | 269,386 (0%) | 0% | 0 | Common Stock | |
| Exact Sciences Corp | Kevin T. Conroy | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Mar 2026 | 119,312 | 1,397,738 (0%) | 0% | 0 | Common Stock | |
| Alignment Healthcare Inc | John E. Kao | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 17.48 per share. | 23 Mar 2026 | 118,000 | 2,354,641 | - | 17.5 | 2,062,439 | Common Stock |
| Exact Sciences Corp | Kevin T. Conroy | Director, President and CEO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 23 Mar 2026 | 117,427 | 0 (0%) | 0% | - | Common Stock | |
| Smith & Nephew PLC (ADR) | Deepak S. Nath | Executive Director,Chief Executive Officer | 23 Mar 2026 | 109,650 | 410,468 (0%) | 0% | 0 | Ords 0.20p | ||
| Exact Sciences Corp | Kevin T. Conroy | Director, President and CEO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 23 Mar 2026 | 100,916 | 0 | - | - | Stock Options (Right to Buy) | |
| Janus Living Inc Ordinary | Scott M. Brinker | Director, PRESIDENT & CEO | Purchase of securities on an exchange or from another person at price $ 20.00 per share. | 23 Mar 2026 | 100,000 | 100,000 | - | 20 | 2,000,000 | Class A-1 Common Stock |
| EyePoint Pharma Inc | Jay S. Duker | Director, President and CEO | Other type of transaction at price $ 0.00 per share. | 23 Mar 2026 | 97,500 | 97,500 | - | - | Stock Option (Right to Buy) | |
| EyePoint Pharma Inc | Jay S. Duker | Director, President and CEO | Other type of transaction at price $ 0.00 per share. | 23 Mar 2026 | 97,500 | 82,500 | - | - | Stock Option (Right to Buy) | |
| Orchid Island Cap Inc | George H. Haas | Director, Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Mar 2026 | 93,184 | 170,682 (0%) | 0% | 0 | Common Stock | |
| Orchid Island Cap Inc | George H. Haas | Director, Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Mar 2026 | 93,184 | 104,003 | - | - | Performance Units | |
| British American Tobacco PLC (ADR) | Tadeu Marroco | Executive Director,Chief Executive Officer | 23 Mar 2026 | 90,972 | 16,343 (0%) | 0% | 0 | Ords 0.25p | ||
| British American Tobacco PLC (ADR) | Tadeu Marroco | Executive Director,Chief Executive Officer | 23 Mar 2026 | 90,972 | 0 (0%) | 0% | 0 | Ords 0.25p | ||
| Exact Sciences Corp | Aaron Bloomer | EVP, Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Mar 2026 | 89,911 | 138,679 (0%) | 0% | 0 | Common Stock | |
| Exact Sciences Corp | Kevin T. Conroy | Director, President and CEO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 23 Mar 2026 | 86,750 | 0 (0%) | 0% | - | Common Stock | |
| Exact Sciences Corp | Kevin T. Conroy | Director, President and CEO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 23 Mar 2026 | 83,360 | 0 | - | - | Restricted Stock Units | |
| VSee Health Inc | Imoigele P. Aisiku | Director, Co-Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.61 per share. | 23 Mar 2026 | 78,689 | 3,416,689 | - | 0.6 | 48,000 | Common Stock, par value $0.0001 per share |
| EyePoint Pharma Inc | Jay S. Duker | Director, President and CEO | Other type of transaction at price $ 13.11 per share. | 23 Mar 2026 | 76,766 | 986 (0%) | 0% | 13.1 | 1,006,402 | Common Stock |
| EyePoint Pharma Inc | Jay S. Duker | Director, President and CEO | Other type of transaction at price $ 13.11 per share. | 23 Mar 2026 | 76,766 | 177,431 (0%) | 0% | 13.1 | 1,006,402 | Common Stock |
| Red Robin Gourmet Burgers Inc | Sarah A. Mussetter | CHIEF LEGAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Mar 2026 | 69,350 | 69,350 | - | - | Phantom Restricted Stock Unit | |
| Exact Sciences Corp | James Herriott | SVP, General Counsel & Sec | Sale or transfer of securities back to the company at price $ 0.00 per share. | 23 Mar 2026 | 68,195 | 0 (0%) | 0% | - | Common Stock | |
| VSee Health Inc | Jerry Leonard | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.37 per share. | 23 Mar 2026 | 66,845 | 710,938 | - | 0.4 | 24,733 | Common Stock, par value $0.0001 per share |
| Exact Sciences Corp | Kevin T. Conroy | Director, President and CEO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 23 Mar 2026 | 66,047 | 0 | - | - | Stock Options (Right to Buy) | |
| Amprius Tech Inc | Kang Sun | Director | Sale of securities on an exchange or to another person at price $ 19.06 per share. | 23 Mar 2026 | 65,046 | 56,406 | - | 19.1 | 1,239,705 | Common stock |
| Haleon PLC (ADR) | Brian James McNamara | Chief Executive Officer and Director | Sale of securities on an exchange or to another person at price $ 3.68 per share. | 23 Mar 2026 | 63,012 | 2,128,714 (0%) | 0% | 3.7 | 232,163 | Ords 0.01p |
| Exact Sciences Corp | Sarah Condella | EVP, Human Resources | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Mar 2026 | 60,389 | 191,891 (0%) | 0% | 0 | Common Stock | |
| Janus Living Inc Ordinary | John Arabia | Director | Purchase of securities on an exchange or from another person at price $ 20.00 per share. | 23 Mar 2026 | 60,000 | 67,500 | - | 20 | 1,200,000 | Class A-1 Common Stock |
| US Foods Holding Corp | David E. Flitman | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Mar 2026 | 55,973 | 443,750 (0%) | 0% | 0 | Common Stock | |
| Exact Sciences Corp | Katherine S. Zanotti | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 23 Mar 2026 | 55,361 | 5,398 (0%) | 0% | - | Common Stock | |
| Exact Sciences Corp | Jacob Orville | EVP, GM, Screening | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Mar 2026 | 53,323 | 153,726 (0%) | 0% | 0 | Common Stock | |
| Exact Sciences Corp | James E. Doyle | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 23 Mar 2026 | 52,564 | 5,398 (0%) | 0% | - | Common Stock | |
| EyePoint Pharma Inc | Jay S. Duker | Director, President and CEO | Other type of transaction at price $ 0.00 per share. | 23 Mar 2026 | 52,500 | 52,500 | - | - | Stock Option (Right to Buy) | |
| EyePoint Pharma Inc | Jay S. Duker | Director, President and CEO | Other type of transaction at price $ 0.00 per share. | 23 Mar 2026 | 52,500 | 7,800 | - | - | Stock Option (Right to Buy) | |
| Exact Sciences Corp | D. Scott Coward | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 23 Mar 2026 | 52,164 | 5,398 (0%) | 0% | - | Common Stock | |
| Accelerant Holdings (Class A) | Jay Michael Green | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 12.77 per share. | 23 Mar 2026 | 50,000 | 1,175,589 | - | 12.8 | 638,285 | Class A Common Shares |
| Orchid Island Cap Inc | Robert E. Cauley | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 6.82 per share. | 23 Mar 2026 | 49,790 | 219,596 (0%) | 0% | 6.8 | 339,568 | Common Stock |
| Exact Sciences Corp | Kevin T. Conroy | Director, President and CEO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 23 Mar 2026 | 46,538 | 0 (0%) | 0% | - | Common Stock | |
| Smith & Nephew PLC (ADR) | Deepak S. Nath | Executive Director,Chief Executive Officer | 23 Mar 2026 | 45,220 | 427,050 (0%) | 0% | 0 | Ords 0.20p | ||
| Smith & Nephew PLC (ADR) | Deepak S. Nath | Executive Director,Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 11.94 per share. | 23 Mar 2026 | 44,994 | 365,474 (0%) | 0% | 11.9 | 537,167 | Ords 0.20p |
| Exact Sciences Corp | Kevin T. Conroy | Director, President and CEO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 23 Mar 2026 | 44,336 | 0 | - | - | Restricted Stock Units | |
| VSee Health Inc | Imoigele P. Aisiku | Director, Co-Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 1.16 per share. | 23 Mar 2026 | 41,379 | 3,338,000 | - | 1.2 | 48,000 | Common Stock, par value $0.0001 per share |
| VSee Health Inc | Jerry Leonard | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.61 per share. | 23 Mar 2026 | 40,984 | 644,093 | - | 0.6 | 25,000 | Common Stock, par value $0.0001 per share |
| Kaltura Inc | Ron Yekutiel | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 1.23 per share. | 23 Mar 2026 | 40,475 | 15,055,748 | - | 1.2 | 49,626 | Common Stock |
| Kaltura Inc | Richard Levandov | Director | Purchase of securities on an exchange or from another person at price $ 1.22 per share. | 23 Mar 2026 | 40,000 | 489,706 | - | 1.2 | 48,920 | Common Stock |
| AST SpaceMobile Inc (Class A) | Huiwen Yao | Chief Technology Officer | Sale of securities on an exchange or to another person at price $ 88.88 per share. | 23 Mar 2026 | 40,000 | 4,750 | - | 88.9 | 3,555,200 | Class A Common Stock |
| VSee Health Inc | Imoigele P. Aisiku | Director, Co-Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 1.20 per share. | 23 Mar 2026 | 40,000 | 3,296,621 | - | 1.2 | 48,000 | Common Stock, par value $0.0001 per share |
| Exact Sciences Corp | Jacob Orville | EVP, GM, Screening | Sale or transfer of securities back to the company at price $ 0.00 per share. | 23 Mar 2026 | 38,707 | 0 | - | - | Restricted Stock Units | |
| Red Robin Gourmet Burgers Inc | Jesse Griffith | Chief Operations Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Mar 2026 | 38,636 | 38,636 | - | - | Phantom Restricted Stock Unit | |
| BCP Investment Corp | Dean C. Kehler | Director | Sale of securities on an exchange or to another person at price $ 7.38 per share. | 23 Mar 2026 | 37,100 | 20,649 (0%) | 0% | 7.4 | 273,694 | Common Stock |
| Orchid Island Cap Inc | George H. Haas | Director, Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 6.82 per share. | 23 Mar 2026 | 36,896 | 133,786 (0%) | 0% | 6.8 | 251,631 | Common Stock |
| Exact Sciences Corp | Kevin T. Conroy | Director, President and CEO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 23 Mar 2026 | 34,110 | 0 | - | - | Stock Options (Right to Buy) | |
| Red Robin Gourmet Burgers Inc | Humera Kassem | Chief People Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Mar 2026 | 34,090 | 34,090 | - | - | Phantom Restricted Stock Unit | |
| Exact Sciences Corp | Brian Baranick | EVP, GM, Precision Oncology | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Mar 2026 | 33,321 | 137,195 (0%) | 0% | 0 | Common Stock | |
| Establishment Labs Holdings Inc | Juan Jose Chacon Quiros | Director | Sale of securities on an exchange or to another person at price $ 60.23 per share. | 23 Mar 2026 | 31,425 | 1,226,079 (5%) | 0% | 60.2 | 1,892,791 | Common Shares |
| Kaltura Inc | Naama Halevi Davidov | Director | Sale of securities on an exchange or to another person at price $ 1.22 per share. | 23 Mar 2026 | 30,047 | 206,762 | - | 1.2 | 36,702 | Common Stock |
| Assured Guaranty Ltd | Dominic J. Frederico | Director, President/CEO/Deputy Chairman | Sale of securities on an exchange or to another person at price $ 81.41 per share. | 23 Mar 2026 | 29,998 | 1,264,295 (1%) | 0% | 81.4 | 2,442,137 | Common Shares |
| Exact Sciences Corp | Kevin T. Conroy | Director, President and CEO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 23 Mar 2026 | 29,061 | 0 (0%) | 0% | - | Common Stock | |
| Exact Sciences Corp | Brian Baranick | EVP, GM, Precision Oncology | Sale or transfer of securities back to the company at price $ 0.00 per share. | 23 Mar 2026 | 28,063 | 0 | - | - | Restricted Stock Units | |
| Exact Sciences Corp | Aaron Bloomer | EVP, Chief Financial Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 23 Mar 2026 | 28,063 | 0 | - | - | Restricted Stock Units | |
| Smith & Nephew PLC (ADR) | Deepak S. Nath | Executive Director,Chief Executive Officer | 23 Mar 2026 | 27,739 | 393,213 (0%) | 0% | 0 | Ords 0.20p | ||
| Miami Intl Holdings Inc | Shelly Brown | EVP, Chief Strategy Officer | Sale of securities on an exchange or to another person at price $ 39.33 per share. | 23 Mar 2026 | 25,932 | 299,197 | - | 39.3 | 1,019,906 | Common Stock |
| Janus Living Inc Ordinary | Scott M. Brinker | Director, PRESIDENT & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Mar 2026 | 25,000 | 25,000 | - | - | LTIP Units | |
| Impinj Inc | Chris Diorio | Director, CHIEF EXECUTIVE OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Mar 2026 | 24,806 | 24,806 | - | - | Restricted Stock Units | |
| Crowdstrike (Class A) | George R. Kurtz | Director, PRESIDENT AND CEO | Sale of securities on an exchange or to another person at price $ 411.07 per share. | 23 Mar 2026 | 24,274 | 2,169,666 (5%) | 0% | 411.1 | 9,978,313 | Class A common stock |
| Exact Sciences Corp | Sarah Condella | EVP, Human Resources | Sale or transfer of securities back to the company at price $ 0.00 per share. | 23 Mar 2026 | 23,224 | 0 | - | - | Restricted Stock Units | |
| Exact Sciences Corp | Sarah Condella | EVP, Human Resources | Sale or transfer of securities back to the company at price $ 0.00 per share. | 23 Mar 2026 | 21,948 | 0 | - | - | Stock Options (Right to Buy) | |
| VSee Health Inc | Jerry Leonard | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 1.16 per share. | 23 Mar 2026 | 21,552 | 603,109 | - | 1.2 | 25,000 | Common Stock, par value $0.0001 per share |
| Viatris | Paul B. Campbell | See Remarks | Sale of securities on an exchange or to another person at price $ 13.28 per share. | 23 Mar 2026 | 21,350 | 366,288 (0%) | 0% | 13.3 | 283,539 | Common Stock |
| VSee Health Inc | Jerry Leonard | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 1.20 per share. | 23 Mar 2026 | 20,833 | 581,557 | - | 1.2 | 25,000 | Common Stock, par value $0.0001 per share |
| Exact Sciences Corp | Paul J. Clancy | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 23 Mar 2026 | 20,640 | 5,398 (0%) | 0% | - | Common Stock | |
| Exact Sciences Corp | James Herriott | SVP, General Counsel & Sec | Sale or transfer of securities back to the company at price $ 0.00 per share. | 23 Mar 2026 | 20,321 | 0 | - | - | Restricted Stock Units | |
| Crowdstrike (Class A) | Michael Sentonas | PRESIDENT | Sale of securities on an exchange or to another person at price $ 411.06 per share. | 23 Mar 2026 | 19,367 | 406,944 (0%) | 0% | 411.1 | 7,960,999 | Class A common stock |
| Smith & Nephew PLC (ADR) | Deepak S. Nath | Executive Director,Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 11.94 per share. | 23 Mar 2026 | 18,587 | 408,463 (0%) | 0% | 11.9 | 221,903 | Ords 0.20p |
| Exact Sciences Corp | Kevin T. Conroy | Director, President and CEO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 23 Mar 2026 | 18,143 | 0 | - | - | Restricted Stock Units | |
| Exact Sciences Corp | Shacey Petrovic | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 23 Mar 2026 | 16,406 | 5,398 (0%) | 0% | - | Common Stock | |
| Janus Living Inc Ordinary | Adam G. Mabry | CHIEF INVESTMENT OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Mar 2026 | 15,000 | 15,000 | - | - | LTIP Units | |
| Janus Living Inc Ordinary | Kelvin O. Moses | CHIEF FINANCIAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Mar 2026 | 15,000 | 15,000 | - | - | LTIP Units | |
| Exact Sciences Corp | Leslie L. Trigg | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 23 Mar 2026 | 13,925 | 0 (0%) | 0% | - | Common Stock | |
| Smith & Nephew PLC (ADR) | John Terence Rogers | Executive Director,Chief Financial Officer | 23 Mar 2026 | 13,902 | 85,822 (0%) | 0% | 0 | Ords 0.20p | ||
| Janus Living Inc Ordinary | Katherine A. Sandstrom | Director | Purchase of securities on an exchange or from another person at price $ 20.00 per share. | 23 Mar 2026 | 13,500 | 21,000 | - | 20 | 270,000 | Class A-1 Common Stock |
| US Foods Holding Corp | Dirk J. Locascio | EVP, Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Mar 2026 | 13,434 | 118,511 (0%) | 0% | 0 | Common Stock | |
| Exact Sciences Corp | D. Scott Coward | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 23 Mar 2026 | 12,875 | 0 | - | - | Stock Options (Right to Buy) | |
| Janus Living Inc Ordinary | Jeffrey H. Miller | CHIEF OPERATING OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Mar 2026 | 12,500 | 12,500 | - | - | LTIP Units | |
| Exact Sciences Corp | Sarah Condella | EVP, Human Resources | Sale or transfer of securities back to the company at price $ 0.00 per share. | 23 Mar 2026 | 11,700 | 0 | - | - | Stock Options (Right to Buy) | |
| Smith & Nephew PLC (ADR) | Deepak S. Nath | Executive Director,Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 11.94 per share. | 23 Mar 2026 | 11,383 | 381,830 (0%) | 0% | 11.9 | 135,898 | Ords 0.20p |
| Outfront Media Inc | Manuel A. Diaz Rodriguez | Director | Sale of securities on an exchange or to another person at price $ 26.93 per share. | 23 Mar 2026 | 11,271 | 36,244 (0%) | 0% | 26.9 | 303,528 | Common Stock |
| Atlas Energy Soln Inc (Class A) | John G. Turner | Director, CEO and President, Ten Percent Owner, Member of 10% Owner Group | Payment of exercise price or tax liability using portion of securities received from the company at price $ 13.48 per share. | 23 Mar 2026 | 11,246 | 656,678 | - | 13.5 | 151,596 | Common Stock |
| Exact Sciences Corp | D. Scott Coward | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 23 Mar 2026 | 10,786 | 0 | - | - | Stock Options (Right to Buy) | |
| US Foods Holding Corp | John A. Tonnison | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Mar 2026 | 10,635 | 121,442 (0%) | 0% | 0 | Common Stock | |
| US Foods Holding Corp | Timothy D. Johnson | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Mar 2026 | 10,635 | 38,670 (0%) | 0% | 0 | Common Stock | |
| US Foods Holding Corp | Steven M. Guberman | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Mar 2026 | 10,635 | 121,263 (0%) | 0% | 0 | Common Stock | |
| US Foods Holding Corp | Randy J. Taylor | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Mar 2026 | 10,635 | 73,701 (0%) | 0% | 0 | Common Stock | |
| Circle Internet Grp Inc (Class A) | Nikhil Chandhok | Chief Product & Tech. Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Mar 2026 | 10,000 | 1,119,677 | - | - | Stock Option (Right to Buy) | |
| Circle Internet Grp Inc (Class A) | Nikhil Chandhok | Chief Product & Tech. Officer | Sale of securities on an exchange or to another person at price $ 123.08 per share. | 23 Mar 2026 | 10,000 | 540,376 | - | 123.1 | 1,230,800 | Class A Common Stock |
| Circle Internet Grp Inc (Class A) | Nikhil Chandhok | Chief Product & Tech. Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 25.81 per share. | 23 Mar 2026 | 10,000 | 550,376 | - | 25.8 | 258,100 | Class A Common Stock |
| Janus Living Inc Ordinary | Shawn G. Johnston | EVP & CHIEF ACCOUNTING OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Mar 2026 | 10,000 | 10,000 | - | - | LTIP Units | |
| Janus Living Inc Ordinary | Ankit B. Patadia | EVP AND TREASURER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Mar 2026 | 10,000 | 10,000 | - | - | LTIP Units | |
| Janus Living Inc Ordinary | Tracy A. Porter | EVP & GENERAL COUNSEL | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Mar 2026 | 10,000 | 10,000 | - | - | LTIP Units | |
| United Therapeutics Corp | James C. Edgemond | CFO AND TREASURER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Mar 2026 | 10,000 | 152,500 | - | - | Stock Option | |
| United Therapeutics Corp | James C. Edgemond | CFO AND TREASURER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 135.42 per share. | 23 Mar 2026 | 10,000 | 28,876 (0%) | 0% | 135.4 | 1,354,200 | Common Stock |
| US Foods Holding Corp | David L Poe | EVP, Chief Merchant | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Mar 2026 | 9,852 | 40,910 (0%) | 0% | 0 | Common Stock | |
| US Foods Holding Corp | James David Works | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Mar 2026 | 9,796 | 97,972 (0%) | 0% | 0 | Common Stock | |
| Academy Sports and Outdoors Inc | Kenneth C. Hicks | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Mar 2026 | 9,665 | 463,992 | - | - | Common Stock | |
| Academy Sports and Outdoors Inc | Kenneth C. Hicks | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Mar 2026 | 9,665 | 0 | - | - | Restricted Stock Units | |
| Exact Sciences Corp | Kimberly J. Popovits | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 23 Mar 2026 | 9,656 | 0 (0%) | 0% | - | Common Stock | |
| United Therapeutics Corp | Martine A. Rothblatt | Director, Chairperson & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 146.03 per share. | 23 Mar 2026 | 9,500 | 50,013 (0%) | 0% | 146.0 | 1,387,285 | Common Stock |
| United Therapeutics Corp | Martine A. Rothblatt | Director, Chairperson & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Mar 2026 | 9,500 | 88,000 | - | - | Stock Option | |
| US Foods Holding Corp | William Spencer Hancock | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Mar 2026 | 9,320 | 113,335 (0%) | 0% | 0 | Common Stock | |
| Bicara Therapeutics Inc | Ivan Hyep | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.79 per share. | 23 Mar 2026 | 9,200 | 154,555 | - | 3.8 | 34,866 | Common Stock |
| Bicara Therapeutics Inc | Ivan Hyep | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 18.52 per share. | 23 Mar 2026 | 9,200 | 145,355 | - | 18.5 | 170,348 | Common Stock |
| Bicara Therapeutics Inc | Ivan Hyep | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Mar 2026 | 9,200 | 48,944 | - | - | Stock Option (Right to Buy) | |
| Smith & Nephew PLC (ADR) | John Terence Rogers | Executive Director,Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 11.94 per share. | 23 Mar 2026 | 8,663 | 77,159 (0%) | 0% | 11.9 | 103,424 | Ords 0.20p |
| Red Robin Gourmet Burgers Inc | Sarah A. Mussetter | CHIEF LEGAL OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.08 per share. | 23 Mar 2026 | 8,391 | 98,497 (0%) | 0% | 3.1 | 25,844 | Common Stock |
| Hinge Health Inc (Class A) | James Budge | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 42.45 per share. | 23 Mar 2026 | 8,346 | 402,099 | - | 42.5 | 354,299 | Class A Common Stock |
| Exact Sciences Corp | Sarah Condella | EVP, Human Resources | Sale or transfer of securities back to the company at price $ 0.00 per share. | 23 Mar 2026 | 7,790 | 0 | - | - | Stock Options (Right to Buy) | |
| Exact Sciences Corp | Michael J. Barber | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 23 Mar 2026 | 7,738 | 5,398 (0%) | 0% | - | Common Stock | |
| Vir biotech Inc | Brent Sabatini | SVP, Chief Accounting Officer | Sale of securities on an exchange or to another person at price $ 9.12 per share. | 23 Mar 2026 | 7,711 | 61,902 (0%) | 0% | 9.1 | 70,324 | Common Stock |
| Impinj Inc | Cary Baker | CHIEF FINANCIAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Mar 2026 | 7,627 | 7,627 | - | - | Restricted Stock Units | |
| ReposiTrak | Randall K. Fields | Director, CHIEF EXECUTIVE OFFICER, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 8.06 per share. | 23 Mar 2026 | 7,500 | 70,000 (0%) | 0% | 8.1 | 60,447 | Common Stock |
| Janus Living Inc Ordinary | Jeffrey H. Miller | CHIEF OPERATING OFFICER | Purchase of securities on an exchange or from another person at price $ 20.00 per share. | 23 Mar 2026 | 7,500 | 7,500 | - | 20 | 150,000 | Class A-1 Common Stock |
| Exact Sciences Corp | Michael J. Barber | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 23 Mar 2026 | 7,422 | 0 | - | - | Deferred Stock Units | |
| Crowdstrike (Class A) | Burt W. Podbere | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 411.10 per share. | 23 Mar 2026 | 7,314 | 196,229 (0%) | 0% | 411.1 | 3,006,785 | Class A common stock |
| Exact Sciences Corp | Shacey Petrovic | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 23 Mar 2026 | 7,095 | 0 (0%) | 0% | - | Common Stock | |
| Conoco Phillips | Nicholas G. Olds | Executive Vice President | Sale of securities on an exchange or to another person at price $ 127.06 per share. | 23 Mar 2026 | 6,994 | 5,395 (0%) | 0% | 127.1 | 888,651 | Common Stock |
| BCP Investment Corp | George Grunebaum | Director | Purchase of securities on an exchange or from another person at price $ 7.54 per share. | 23 Mar 2026 | 6,800 | 14,136 (0%) | 0% | 7.5 | 51,271 | Common Stock |
| Exact Sciences Corp | Kimberly J. Popovits | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 23 Mar 2026 | 6,725 | 9,656 (0%) | 0% | - | Common Stock | |
| Kimbell Royalty Partners LP - Units | R. Blayne Rhynsburger | Controller | Sale of securities on an exchange or to another person at price $ 14.48 per share. | 23 Mar 2026 | 6,609 | 75,163 (0%) | 0% | 14.5 | 95,698 | Common units representing limited partner interests |
| Crowdstrike (Class A) | Burt W. Podbere | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 409.42 per share. | 23 Mar 2026 | 6,582 | 204,859 (0%) | 0% | 409.4 | 2,694,802 | Class A common stock |
| Exact Sciences Corp | Jacob Orville | EVP, GM, Screening | Sale or transfer of securities back to the company at price $ 0.00 per share. | 23 Mar 2026 | 6,581 | 0 | - | - | Stock Options (Right to Buy) | |
| Exact Sciences Corp | Sarah Condella | EVP, Human Resources | Sale or transfer of securities back to the company at price $ 0.00 per share. | 23 Mar 2026 | 6,581 | 0 | - | - | Stock Options (Right to Buy) | |
| Exact Sciences Corp | Sarah Condella | EVP, Human Resources | Sale or transfer of securities back to the company at price $ 0.00 per share. | 23 Mar 2026 | 6,368 | 0 (0%) | 0% | - | Common Stock | |
| Acacia Research Corp | Jason W. Soncini | General Counsel | Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.85 per share. | 23 Mar 2026 | 6,147 | 191,551 (0%) | 0% | 4.9 | 29,813 | ACTG Common Stock |
| Marketwise Inc (Class A) | Erik Mickels | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 14.70 per share. | 23 Mar 2026 | 6,000 | 79,064 | - | 14.7 | 88,200 | Class A Common Stock |
| Tidewater Inc - Ordinary Shares - New | Quintin V. Kneen | Director, DIRECTOR, PRESIDENT & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 72.48 per share. | 23 Mar 2026 | 5,872 | 358,870 (0%) | 0% | 72.5 | 425,603 | Common Stock, $0.001 par value |
| Telephone And Data Systems Inc | Prudence E. Carlson | Director | Sale of securities on an exchange or to another person at price $ 42.00 per share. | 23 Mar 2026 | 5,811 | 305,556 (0%) | 0% | 42 | 244,062 | Common Shares |
| Tidewater Inc - Ordinary Shares - New | Quintin V. Kneen | Director, DIRECTOR, PRESIDENT & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 72.48 per share. | 23 Mar 2026 | 5,766 | 367,297 (0%) | 0% | 72.5 | 417,920 | Common Stock, $0.001 par value |
| Janus Living Inc Ordinary | Charles J. Herman | Director | Purchase of securities on an exchange or from another person at price $ 20.00 per share. | 23 Mar 2026 | 5,500 | 13,000 | - | 20 | 110,000 | Class A-1 Common Stock |
| Exact Sciences Corp | Katherine S. Zanotti | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 23 Mar 2026 | 5,398 | 0 (0%) | 0% | - | Common Stock | |
| Exact Sciences Corp | Paul J. Clancy | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 23 Mar 2026 | 5,398 | 0 (0%) | 0% | - | Common Stock | |
| Exact Sciences Corp | James E. Doyle | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 23 Mar 2026 | 5,398 | 0 (0%) | 0% | - | Common Stock | |
| Exact Sciences Corp | D. Scott Coward | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 23 Mar 2026 | 5,398 | 0 (0%) | 0% | - | Common Stock | |
| Exact Sciences Corp | Shacey Petrovic | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 23 Mar 2026 | 5,398 | 0 (0%) | 0% | - | Common Stock | |
| Exact Sciences Corp | Michael J. Barber | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 23 Mar 2026 | 5,398 | 0 (0%) | 0% | - | Common Stock | |
| Janus Living Inc Ordinary | Charles J. Herman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Mar 2026 | 5,000 | 7,500 | - | 0 | Class A-1 Common Stock | |
| Janus Living Inc Ordinary | John Arabia | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Mar 2026 | 5,000 | 7,500 | - | 0 | Class A-1 Common Stock | |
| Janus Living Inc Ordinary | Denise A. Olsen | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Mar 2026 | 5,000 | 7,500 | - | 0 | Class A-1 Common Stock | |
| Janus Living Inc Ordinary | Katherine A. Sandstrom | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Mar 2026 | 5,000 | 7,500 | - | 0 | Class A-1 Common Stock | |
| Exact Sciences Corp | D. Scott Coward | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 23 Mar 2026 | 4,694 | 0 (0%) | 0% | - | Common Stock | |
| Exact Sciences Corp | Aaron Bloomer | EVP, Chief Financial Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 23 Mar 2026 | 4,395 | 0 | - | - | Restricted Stock Units | |
| Horizon Bancorp Inc (IN) | Thomas M. Prame | Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 16.28 per share. | 23 Mar 2026 | 4,345 | 54,980 (0%) | 0% | 16.3 | 70,737 | Common Stock |
| Exact Sciences Corp | D. Scott Coward | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 23 Mar 2026 | 4,175 | 0 | - | - | Stock Options (Right to Buy) | |
| FedEx | R. Brad Martin | Director, Executive Chairman | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Mar 2026 | 4,153 | 36,061 (0%) | 0% | 0 | Common Stock | |
| Exzeo Group Inc | James J. Macchiarola | Director | Purchase of securities on an exchange or from another person at price $ 15.12 per share. | 23 Mar 2026 | 4,000 | 140,000 | - | 15.1 | 60,480 | Common Stock |
| D.R. Horton | Michael J. Murray | EVP and COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Mar 2026 | 3,820 | 127,639 (0%) | 0% | - | Common Stock | |
| D.R. Horton | Michael J. Murray | EVP and COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Mar 2026 | 3,820 | 3,819 | - | - | Restricted Stock Unit | |
| D.R. Horton | Paul J. Romanowski | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Mar 2026 | 3,820 | 3,819 | - | - | Restricted Stock Unit | |
| D.R. Horton | Paul J. Romanowski | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Mar 2026 | 3,820 | 198,481 (0%) | 0% | - | Common Stock | |
| Stock Yards Bancorp Inc | James A. Hillebrand | Director, Chairman & CEO | Grant, award, or other acquisition of securities at price $ 64.46 per share. | 23 Mar 2026 | 3,637 | 110,929 (0%) | 0% | 64.5 | 234,441 | Common Stock |
| Red Robin Gourmet Burgers Inc | Jesse Griffith | Chief Operations Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.08 per share. | 23 Mar 2026 | 3,284 | 38,826 (0%) | 0% | 3.1 | 10,115 | Common Stock |
| Exact Sciences Corp | Leslie L. Trigg | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 23 Mar 2026 | 3,244 | 13,925 (0%) | 0% | - | Common Stock | |
| Vicor Corp | Patrizio Vinciarelli | Director, Chairman and CEO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 175.00 per share. | 23 Mar 2026 | 3,134 | 9,060,953 (31%) | 0% | 175 | 548,450 | Common Stock |
| Academy Sports and Outdoors Inc | Kenneth C. Hicks | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 51.98 per share. | 23 Mar 2026 | 3,116 | 460,876 | - | 52.0 | 161,970 | Common Stock |
This section tracks all disclosures required by the U.S. Securities and Exchange Commission (SEC) under the Securities Exchange Act of 1934, particularly those related to Section 16 and Rule 10b-5, which govern insider trading activities in the U.S. market. These disclosures are made by corporate insiders, including executives, officers, directors, significant employees, and large shareholders, who are buying and selling stock in their own companies. You can search and filter within these results. You can also sort the information by clicking on the column headers.